Project Grant HT9425261E074
Award Date 4/1/26
Completion Date 3/31/29
Dollars Obligated $1.6M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $1.476 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded on August 15, 2025, with a completion date of August 14, 2028. This award supports the development and research of an in situ tumor vaccine designed to stimulate antitumor immunity against breast cancer. The three-year project will be conducted at UT...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $1,311,922 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The award funds research and development activities focused on next-generation renal cell carcinoma (RCC) mouse models designed to reproduce human oncogenotypes and advance therapeutic development. This research initiative...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $319,800 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective November 1, 2025, through October 31, 2028. The award supports research focused on novel hypoxia-inducible factor 2 (HIF-2) regulators and therapeutic targets for kidney cancer treatment. This research initiative aligns with the DHA's mission to...
- Summary of Federal Grant Award The University of Texas Southwestern Medical Center (UT Southwestern) received a $1.23 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for a four-year period beginning August 1, 2025 and concluding July 31, 2029. The award supports research focused on "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in Renal Cell Carcinoma...
- Federal Grant Award Summary The University of Texas Health Science Center at San Antonio received a $750,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective March 1, 2026 through February 28, 2029. The award supports research targeting KDM1A/LSD1 (lysine-specific demethylase 1) to overcome radiation resistance in triple-negative breast cancer brain metastases. This three-year initiative addresses a critical...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $1,062,400 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective November 1, 2025, through October 31, 2029. The project, titled "Identification of NEK5 as a Hidden Driver in Kidney Cancer," supports advanced biomedical research aimed at investigating molecular mechanisms in kidney cancer to develop...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $999,729 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on July 15, 2025, with a completion date of July 14, 2028. This award supports research to vitalize newly formed oligodendrocytes to repair myelin, advancing biomedical research relevant to military healthcare needs. The three-year project is being conducted at UT...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $450,174 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Building on the Foundation of the Academy of Kidney Cancer Investigators." The award, effective September 1, 2025, through August 31, 2030, supports advanced biomedical research focused on kidney cancer investigation and related oncological...
- Federal Project Grant Award Summary The University of Texas Health Science Center at San Antonio received a $1.57M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2029. The grant supports research focused on targeting METTL3 (methyltransferase-like 3) to overcome drug resistance in metastatic clear cell renal cell carcinoma. This four-year initiative represents the...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $1,297,895 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2029. This research initiative, titled "Identification of Immunomodulatory Targets of TAZ/SRF in Sarcomatoid Renal Cell Carcinoma Progression," focuses on investigating molecular and immunological mechanisms...